Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Realm Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary hypochlorous acid-based immunomodulatory therapies, with an initial focus in dermatology and ophthalmology. Its lead programs are in Phase 1 for allergic conjunctivitis and atopic dermatitis, leveraging anti-inflammatory and immunomodulatory properties of its platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Realm Therapeutics, Inc..